Upgrade to SI Premium - Free Trial

Arvinas Inc. (ARVN)

7.64 +0.13 (1.73%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/10/26)

Latest Headlines

Arvinas shares Phase 1 ARV-102 data for Parkinson's disease October 7, 2026 7:00 AM - StreetInsider Arvinas Shares Novel Oculomotor and Biomarker Data from Phase 1 Clinical Trial of ARV-102 in Patients with Parkinson’s Disease October 7, 2026 7:00 AM - StreetInsider Arvinas to present ARV-102 Parkinson's trial data at MDS congress October 1, 2026 4:01 PM - StreetInsider Arvinas to Present Novel Biomarker Data from the Phase 1 Clinical Trial for ARV-102, a PROTAC LRRK2 Degrader, at the 2026 International Congress of Parkinson’s Disease and Movement Disorders® October 1, 2026 4:01 PM - StreetInsider Arvinas Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) September 29, 2026 4:01 PM - StreetInsider Form S-8 ARVINAS, INC. September 28, 2026 4:03 PM - SEC Filing Arvinas doses first patient in ARV-6723 Phase 1/2 trial September 28, 2026 7:00 AM - StreetInsider Arvinas Announces First Patient Dosed in Phase 1/2 Clinical Trial of ARV-6723, the Company’s First Immuno-Oncology Candidate September 28, 2026 7:00 AM - StreetInsider Form 144 ARVINAS, INC. Filed by: AGARWAL SUNIL September 22, 2026 4:36 PM - SEC Filing Arvinas to Participate in Upcoming Investor Conferences September 3, 2026 4:01 PM - StreetInsider Arvinas Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) September 1, 2026 4:01 PM - StreetInsider Piper Sandler on Biotechnology: 'Look for Biotech to Outperform through YE:26' September 1, 2026 9:07 AM - StreetInsider Form SCHEDULE 13G/A ARVINAS, INC. Filed by: D. E. SHAW & CO, L.P. August 14, 2026 4:25 PM - SEC Filing Arvinas Inc. (ARVN) PT Lowered to $10 at Morgan Stanley August 10, 2026 8:36 AM - StreetInsider Form 144 ARVINAS, INC. Filed by: Berkowitz Noah August 4, 2026 4:13 PM - SEC Filing Form 10-Q ARVINAS, INC. For: Jun 30 August 4, 2026 4:10 PM - SEC Filing Wells Fargo Downgrades Arvinas Inc. (ARVN) to Equal Weight August 4, 2026 1:11 PM - StreetInsider BTIG Reiterates Buy Rating on Arvinas Inc. (ARVN) August 4, 2026 1:08 PM - StreetInsider Arvinas, Inc. (ARVN) Tops Q2 EPS by 296c August 4, 2026 7:28 AM - StreetInsider Form 8-K ARVINAS, INC. For: Aug 04 August 4, 2026 7:02 AM - SEC Filing Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update August 4, 2026 7:00 AM - StreetInsider Arvinas to Report Second Quarter 2026 Financial Results on August 4, 2026 July 28, 2026 7:00 AM - StreetInsider Full Article List